Literature DB >> 16159972

Sudden cardiac death: opportunities for prevention.

J M Morgan, J C Cowan, A J Camm, J M McComb.   

Abstract

The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy.

Entities:  

Mesh:

Year:  2005        PMID: 16159972      PMCID: PMC1860649          DOI: 10.1136/hrt.2005.073726

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

1.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

2.  Update of the guidelines on sudden cardiac death of the European Society of Cardiology.

Authors:  Silvia G Priori; Etienne Aliot; Carina Blomstrom-Lundqvist; Leo Bossaert; Gunter Breithardt; Pedro Brugada; John A Camm; Riccardo Cappato; Stuart M Cobbe; Carlo Di Mario; Barry J Maron; William J McKenna; Anders K Pedersen; Ursula Ravens; Peter J Schwartz; Maria Trusz-Gluza; Panos Vardas; Hein J J Wellens; Douglas P Zipes
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

Review 3.  Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.

Authors:  Anthony S Tang; Heather Ross; Christopher S Simpson; L Brent Mitchell; Paul Dorian; Ron Goeree; Barry Hoffmaster; Malcolm Arnold; Mario Talajic
Journal:  Can J Cardiol       Date:  2005-05       Impact factor: 5.223

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.

Authors:  R Sheldon; B J O'Brien; G Blackhouse; R Goeree; B Mitchell; G Klein; R S Roberts; M Gent; S J Connolly
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

6.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

7.  Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.

Authors:  Riccardo Cappato; Sigrid Boczor; Karl-Heinz Kuck
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

8.  Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Authors:  Michael A Brodsky; L Brent Mitchell; Blair D Halperin; Merritt H Raitt; Alfred P Hallstrom
Journal:  Am Heart J       Date:  2002-09       Impact factor: 4.749

9.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Authors:  Bruce L Wilkoff; James R Cook; Andrew E Epstein; H Leon Greene; Alfred P Hallstrom; Henry Hsia; Steven P Kutalek; Arjun Sharma
Journal:  JAMA       Date:  2002-12-25       Impact factor: 56.272

10.  The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review.

Authors:  J L Burke; C N Hallas; D Clark-Carter; D White; D Connelly
Journal:  Br J Health Psychol       Date:  2003-05
View more
  2 in total

Review 1.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

2.  Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy.

Authors:  Fazıl Arısoy; Ozlem Ozcan Celebi; İlke Erbay; Omaç Tufekcioglu; Sinan Aydoğdu; Ahmet Temizhan
Journal:  J Arrhythm       Date:  2021-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.